Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP815761.RA5HNuCLG0Ft22QdQsslOc6s8UzcKcM7RKfz96hZzzW2E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP815761.RA5HNuCLG0Ft22QdQsslOc6s8UzcKcM7RKfz96hZzzW2E130_assertion type Assertion NP815761.RA5HNuCLG0Ft22QdQsslOc6s8UzcKcM7RKfz96hZzzW2E130_head.
- NP815761.RA5HNuCLG0Ft22QdQsslOc6s8UzcKcM7RKfz96hZzzW2E130_assertion wasGeneratedBy ECO_0000203 NP815761.RA5HNuCLG0Ft22QdQsslOc6s8UzcKcM7RKfz96hZzzW2E130_provenance.
- NP815761.RA5HNuCLG0Ft22QdQsslOc6s8UzcKcM7RKfz96hZzzW2E130_assertion wasDerivedFrom befree-2016 NP815761.RA5HNuCLG0Ft22QdQsslOc6s8UzcKcM7RKfz96hZzzW2E130_provenance.
- NP815761.RA5HNuCLG0Ft22QdQsslOc6s8UzcKcM7RKfz96hZzzW2E130_assertion SIO_000772 20514303 NP815761.RA5HNuCLG0Ft22QdQsslOc6s8UzcKcM7RKfz96hZzzW2E130_provenance.
- NP815761.RA5HNuCLG0Ft22QdQsslOc6s8UzcKcM7RKfz96hZzzW2E130_assertion evidence source_evidence_literature NP815761.RA5HNuCLG0Ft22QdQsslOc6s8UzcKcM7RKfz96hZzzW2E130_provenance.
- NP815761.RA5HNuCLG0Ft22QdQsslOc6s8UzcKcM7RKfz96hZzzW2E130_assertion description "[Identification of prognostic factors and risk-based post-remission therapy was proposed to improve the outcomes of acute myeloid leukemia (AML) and a mutation of FLT3 has been reported to be a risk factor, especially for pediatric patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815761.RA5HNuCLG0Ft22QdQsslOc6s8UzcKcM7RKfz96hZzzW2E130_provenance.